Drug Eluting Balloons Catheters Market to Reach $2.62 Billion by 2029, Expanding at 12.2% CAGR

 Tailored for companies operating in or entering the drug eluting balloons catheters sector, this analysis highlights core growth drivers, risks, and innovation trends.

 



 What Is The Expected CAGR For The Drug Eluting Balloons Catheters Market Through 2025?
 The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.43 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increasing respiratory disorders, advantages over traditional inhalers, patient preference for dpis, government initiatives for respiratory health, strategic collaborations and partnerships, advancements in drug formulations, rising geriatric population.
 
 The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.62 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to continued growth in respiratory disorders, expanding geriatric population, increasing awareness and education, market expansion in emerging economies, customized drug formulations, regulatory support and compliance, innovations in packaging and design. Major trends in the forecast period include smart inhalers and connectivity, shift towards breath-actuated inhalers, focus on pediatric and geriatric patient needs, biologics delivery, environmentally friendly inhaler designs.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp
 
 Which Key Factors Will Influence Drug Eluting Balloons Catheters Market Growth Over 2025–2034?
 The growing prevalence of peripheral and cardiovascular diseases is expected to propel the growth of the drug-eluting balloon catheter market going forward. Cardiovascular diseases (CVDs) refer to a group of conditions that impact the heart and the circulatory system, whereas peripheral artery disease (PAD) specifically refers to a condition where narrowed arteries reduce blood flow primarily to the arms or legs. Drug-eluting balloon catheters are a type of treatment for coronary artery disease (CAD) that uses a semi-compliant angioplasty balloon coated with an anti-proliferative substance that, when it enters the vessel, can have an anti-restenotic effect. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2022 heart disease claimed the lives of 702,880 people, accounting for 1 in every 5 deaths. Each year in the United States, approximately 805,000 people experience a heart attack. Of these, 605,000 are first-time heart attacks, while 200,000 occur in individuals who have already had one. Therefore, the growing prevalence of peripheral and cardiovascular diseases is driving the drug-eluting balloon catheter market. 
 
 Comprehensive Segment-Wise Insights Into The Drug Eluting Balloons Catheters Market
 The drug eluting balloons catheters market covered in this report is segmented — 
 
 1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
 2) By Drug: Paclitaxel, Sirolimus, Other Drugs
 3) By Raw Material: Nylon, Polyurethane, Other Raw Materials
 4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories
 
 Subsegments:
 1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters, Plain Balloon Catheters
 2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters, Angioplasty Balloon Catheters
 3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
 
 What Are The Prominent Trends In The Drug Eluting Balloons Catheters Market?
 Major companies operating in the drug-eluting balloon catheter market are increasing their focus on developing the newest-generation products with advanced technologies to gain a competitive edge in the market. For instance, in March 2024, Boston Scientific Corporation, a US-based biomedical/biotechnology engineering firm and multinational manufacturer of medical devices, announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). AGENT DCB is the first drug-coated coronary balloon available in the U.S. for treating in-stent restenosis (ISR), where plaque or scar tissue blocks a stented vessel. It features a paclitaxel coating that delivers a therapeutic dose to the vessel wall, reducing ISR recurrence without additional stents or radiation. Clinical trials showed a 49% decrease in heart attack risk at the target site and reported low rates of adverse events. 
 
 Analysis Of Key Players In Drug Eluting Balloons Catheters Market
 Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB
 
 View the full drug eluting balloons catheters market report here:
 https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report
 
 What Are The Key Regional Trends In The Drug Eluting Balloons Catheters Market?
 North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more